Fig. 3: Pre- and post-treatment immune cell subsets. | British Journal of Cancer

Fig. 3: Pre- and post-treatment immune cell subsets.

From: Alterations in immune cell phenotype and cytotoxic capacity in HER2+ breast cancer patients receiving HER2-targeted neo-adjuvant therapy

Fig. 3: Pre- and post-treatment immune cell subsets.The alternative text for this image may have been generated using AI.

Proportion of CD45+ cells staining positive for a CD3, b CD4, c CD8, d CD56, e CD19, f CD14, and g PD-1 in paired pre- and post-treatment samples. A paired Student’s t test was used to determine statistical significance, all p values were corrected for multiple testing. *p < 0.05, **p < 0.01, ***p < 0.001, NS not significant.

Back to article page